Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 7:103:adv00861.
doi: 10.2340/actadv.v103.4804.

Serum Interleukin-13 and Caspase 8 are Elevated in Prurigo Nodularis

Affiliations

Serum Interleukin-13 and Caspase 8 are Elevated in Prurigo Nodularis

Teresa Ju et al. Acta Derm Venereol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

GY has served as an advisory board member, investigator and/or received consulting fees from Galderma, Pfizer, Sanofi Regeneron, Novartis, Eli Lilly, Kiniksa, Vellus and Cell Dex. SE, AA, SS, JTS, ZS and AO are all employees and potentially stockholders of Eli Lilly. All other authors have no additional conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1
Volcano plot of proteomic assays showing analytes with > 1.3-fold changes that were significant (qval < 0.05). Blue circles represent analytes significantly reduced in prurigo nodularis (PN) vs healthy controls (HC). Red circles represent analytes significantly elevated in PN vs HC. “S” indicates single-plex assay. Protein markers with missing data frequency > 80% were removed from Olink data analysis (IL20RA, IL2RB, IL1 alpha, IL2, IL22RA1, Beta-NGF, IL13, ARTN, IL20, IL33, LIF, NRTN, IL5). FLT3L: fms-related tyrosine kinase 3 ligand. IL13_S: interleukin 13 from single-plex analysis. TRAIL: tumour necrosis factor-related apoptosis-inducing ligand. IL17C: interleukin-17 C.

References

    1. Ingrasci G, Lipman ZM, Hawash AA, Girolomoni G, Yosipovitch G. The pruritogenic role of the type 2 immune response in diseases associated with chronic itch. Exp Dermatol 2021; 30: 1208–1217. - PubMed
    1. Mikhaylov D, Del Duca E, Guttman-Yassky E. Proteomic signatures of inflammatory skin diseases: a focus on atopic dermatitis. Expert Rev Proteomics 2021; 18: 345–361. - PubMed
    1. Engle SM, Chang CY, Ulrich BJ, Satterwhite A, Hayes T, Robling K, et al. . Predictive biomarker modeling of pediatric atopic dermatitis severity based on longitudinal serum collection. Clin Exp Immunol 2021; 207: 253–262. - PMC - PubMed
    1. Belzberg M, Alphonse MP, Brown I, Williams KA, Khanna R, Ho B, et al. . Prurigo nodularis is characterized by systemic and cutaneous T helper 22 immune polarization. J Invest Dermatol 2021; 141: 2208–2218.e14. - PMC - PubMed
    1. Tsoi LC, Hacini-Rachinel F, Fogel P, Rousseau F, Xing X, Patrick MT, et al. ., Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab. J Allergy Clin Immunol 2022; 149: 1329–1339. - PMC - PubMed

LinkOut - more resources